World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
57874
World Ranking
15335
National Ranking
7732

Overview

Xuhong Cao is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, and Immunology.

The scientist's work frequently addresses topics such as Prostate Cancer Treatment and Research, Protein Degradation and Inhibitors, Renal Cell Carcinoma Treatment, Cancer Genomics and Diagnostics, Renal and Related Cancers, Chromatin Remodeling and Cancer, and Ubiquitin and Proteasome Pathways.

Recent publications by Xuhong Cao include:

  • Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination, 2021, Nature Medicine
  • Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response, 2021, Proceedings of the National Academy of Sciences
  • Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer, 2021, Nature
  • Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2, 2020, Proceedings of the National Academy of Sciences
  • Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors, 2021, JAMA Oncology

The scientist frequently publishes in venues including:

  • Cancer Research
  • Proceedings of the National Academy of Sciences
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neoplasia
  • Neuro-Oncology

Xuhong Cao collaborates often with several coauthors, notably Arul M. Chinnaiyan, Rahul Mannan, Fengyun Su, Rohit Mehra, and Lanbo Xiao. These collaborations reflect sustained research partnerships contributing to the body of knowledge in their fields.

Best Publications

  • Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

    S.A. Tomlins;D.R. Rhodes;S. Perner;S.M. Dhanasekaran

  • Integrative clinical genomics of advanced prostate cancer

    Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • The mutational landscape of lethal castration-resistant prostate cancer

    Catherine S. Grasso;Yi Mi Wu;Dan R. Robinson;Xuhong Cao

  • The landscape of long noncoding RNAs in the human transcriptome

    Matthew K. Iyer;Yashar S. Niknafs;Rohit Malik;Udit Singhal

  • Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

    Arun Sreekumar;Laila M. Poisson;Thekkelnaycke M. Rajendiran;Amjad P. Khan

  • DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.

    Joaquin Mateo;Suzanne Carreira;Shahneen Sandhu;Susana Miranda

  • Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

    Sooryanarayana Varambally;Qi Cao;Ram Shankar Mani;Sunita Shankar

  • Activating ESR1 mutations in hormone-resistant metastatic breast cancer

    Dan R. Robinson;Yi Mi Wu;Pankaj Vats;Fengyun Su

  • The Landscape of Circular RNA in Cancer.

    Josh N. Vo;Marcin Cieslik;Yajia Zhang;Sudhanshu Shukla;Sudhanshu Shukla

  • Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1 , an unannotated lincRNA implicated in disease progression

    John R Prensner;Matthew K Iyer;O Alejandro Balbin;Saravana M Dhanasekaran

  • Integrative molecular concept modeling of prostate cancer progression

    Scott A Tomlins;Rohit Mehra;Daniel R Rhodes;Xuhong Cao

  • Transcriptome Sequencing to Detect Gene Fusions in Cancer

    Christopher A. Maher;Chandan Kumar-Sinha;Xuhong Cao;Shanker Kalyana-Sundaram

  • Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer

    Irfan A. Asangani;Vijaya L. Dommeti;Xiaoju Wang;Rohit Malik

  • Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

    Scott A. Tomlins;Bharathi Laxman;Saravana M. Dhanasekaran;Beth E. Helgeson

  • An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression

    Jindan Yu;Jianjun Yu;Ram Shankar Mani;Qi Cao

  • Integrative clinical genomics of metastatic cancer

    Dan R. Robinson;Yi Mi Wu;Robert J. Lonigro;Pankaj Vats

  • Role of the TMPRSS2-ERG gene fusion in prostate cancer

    Scott A. Tomlins;Bharathi Laxman;Sooryanarayana Varambally;Xuhong Cao

  • Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

    Dan R. Robinson;Yi Mi Wu;Shanker Kalyana-Sundaram;Shanker Kalyana-Sundaram;Xuhong Cao

  • Identification of Targetable FGFR Gene Fusions in Diverse Cancers

    Yi Mi Wu;Fengyun Su;Shanker Kalyana-Sundaram;Nickolay Khazanov

  • The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex

    John R. Prensner;Matthew K. Iyer;Anirban Sahu;Irfan A. Asangani

Frequent Co-Authors

Arul M. Chinnaiyan
Arul M. Chinnaiyan University of Michigan–Ann Arbor
Rohit Mehra
Rohit Mehra University of Michigan–Ann Arbor
Dan R. Robinson
Dan R. Robinson University of Michigan–Ann Arbor
Saravana M. Dhanasekaran
Saravana M. Dhanasekaran University of Michigan–Ann Arbor
Javed Siddiqui
Javed Siddiqui University of Michigan–Ann Arbor
Scott A. Tomlins
Scott A. Tomlins University of Michigan–Ann Arbor
Nallasivam Palanisamy
Nallasivam Palanisamy Henry Ford Health System
Sooryanarayana Varambally
Sooryanarayana Varambally University of Alabama at Birmingham
Kenneth J. Pienta
Kenneth J. Pienta Johns Hopkins University School of Medicine
Jindan Yu
Jindan Yu Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring your options beyond a traditional MD program can open up diverse and flexible career pathways in healthcare. Many students and professionals are turning to online programs for both convenience and affordability.

For registered nurses who want to advance their qualifications, rn to bsn online programs offer a budget-friendly and accessible way to earn a bachelor’s degree. If you do not have a nursing background, direct entry msn programs allow non-nurses to enter the nursing profession at the master’s level, making it possible to switch careers efficiently.

Applicants concerned about admission competitiveness may consider the easiest nursing programs to get into, helping to reduce barriers to entry and start a healthcare career sooner. Additionally, health administration roles are in demand; those interested in behind-the-scenes or remote healthcare work can explore the accredited medical billing and coding schools online with financial aid.

By considering these online degree and certification pathways, you can find a route into the healthcare sector that fits your background, budget, and long-term goals.

Best Scientists Citing Xuhong Cao

Trending Scientists